◆英語タイトル：Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review
◆レポート形式：英語 / PDF
Theravance Biopharma Inc (Theravance) which discovers and develops novel medicines for various diseases.It offers a commercial product, telavancin which is a dual mechanism antibiotic.The company’s pipeline programs include Revefenacin (TD-4208), a long-acting muscarinic antagonist (LAMA) which is being developed as a potential once-daily, nebulized treatment for chronic obstructive pulmonary disease and neprilysin (NEP) inhibitor program is designed to develop selective NEP inhibitors for the treatment of cardiovascular and renal diseases. Theravance develops product candidates for various therapeutic areas such as infectious diseases, respiratory, cardiovascular and gastrointestinal. The company has operational presence in the US and Ireland, Theravance is headquartered in George Town, Cayman Islands, the UK.
Theravance Biopharma Inc Key Recent Developments
Nov 08, 2016: Theravance Biopharma Reports Third Quarter 2016 Financial Results and Provides Business Update
Aug 08, 2016: Theravance Biopharma Reports Second Quarter 2016 Financial Results and Provides Business Update
May 09, 2016: Theravance Biopharma Reports First Quarter 2016 Financial Results and Provides Business Update
Mar 10, 2016: Theravance Biopharma Reports Fourth Quarter and Full Year 2015 Financial Results
Mar 09, 2016: Theravance Biopharma Reports Fourth Quarter and Full Year 2015 Financial Results
This comprehensive SWOT profile of Theravance Biopharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Theravance Biopharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Theravance Biopharma Inc – Key Information
Theravance Biopharma Inc – Overview
Theravance Biopharma Inc – Key Employees
Theravance Biopharma Inc – Key Employee Biographies
Theravance Biopharma Inc – Key Operational Heads
Theravance Biopharma Inc – Major Products and Services
Theravance Biopharma Inc – History
Theravance Biopharma Inc – Company Statement
Theravance Biopharma Inc – Locations And Subsidiaries
Theravance Biopharma Inc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Theravance Biopharma Inc – Business Description
Theravance Biopharma Inc – Corporate Strategy
Theravance Biopharma Inc – SWOT Analysis
SWOT Analysis – Overview
Theravance Biopharma Inc – Strengths
Theravance Biopharma Inc – Weaknesses
Theravance Biopharma Inc – Opportunities
Theravance Biopharma Inc – Threats
Theravance Biopharma Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Theravance Biopharma Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Theravance Biopharma Inc, Key Information
Theravance Biopharma Inc, Key Ratios
Theravance Biopharma Inc, Share Data
Theravance Biopharma Inc, Major Products and Services
Theravance Biopharma Inc, History
Theravance Biopharma Inc, Key Employees
Theravance Biopharma Inc, Key Employee Biographies
Theravance Biopharma Inc, Key Operational Heads
Theravance Biopharma Inc, Other Locations
Theravance Biopharma Inc, Subsidiaries
Theravance Biopharma Inc, Key Manufacturing facilities
Theravance Biopharma Inc, Key Competitors
Theravance Biopharma Inc, SWOT Analysis
Theravance Biopharma Inc, Ratios based on current share price
Theravance Biopharma Inc, Annual Ratios
Theravance Biopharma Inc, Interim Ratios
Capital Market Ratios
List of Figures
Theravance Biopharma Inc, Performance Chart
Theravance Biopharma Inc, Ratio Charts
Theravance Biopharma Inc (TBPH)：企業財務及び戦略的SWOT分析(Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。